PSTV

#4453
PLUS THERAPEUTICS, Inc. Common Stock
5.43 USD
+0.37%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
5.43
5.43
Intervallo Annuale
0.13
5.72
Variazione giornaliera
+0.37%
Variazione Mensile
+1911.11%
Variazione di 6 mesi
+664.79%
Variazione Annuale
+686.96%
Chiusura Precedente
5.41
Apertura
5.43
Bid
Ask
Minimo
5.43
High
5.43
Volume
13
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore 202020212022202320242025 TTM

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Notizie